LENZ

LENZ Therapeutics, Inc.$9.29-0.47 (-4.82%)

Prev Close$9.76·MCap$294.1M·P/E—·Vol408.9K·Yield0.77%

▲

Buys (12M)

$654.9K

▼

Sells (12M)

$261.0K

◆

Net Activity

Net Buyer

$393.8K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at LENZ Therapeutics, Inc. (LENZ) has been dominated by buying, with 5 insider purchases totaling $654.9K and 1 insider sale totaling $261.0K. The most recent insider transaction was by Schimmelpennink Evert B. (director, officer: President, CEO and Secretary), who purchased $251.4K worth of shares on Mar 30, 2026. LENZ Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $294.1M.

LENZ Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2026	Schimmelpennink Evert B.	director, officer: President, CEO and Secretary	Buy	28,089	$8.95	$251.4K	77,289+57%
Mar 30, 2026	George Jeffrey P.	director	Buy	5,592	$8.92	$49.9K	5,592
Mar 30, 2026	Chevallard Daniel R.	officer: Chief Financial Officer	Buy	7,500	$8.57	$64.3K	12,886+139%
Nov 17, 2025	Olsson Shawn	Chief Commercial Officer	Sell	10,000	$26.10	$261.0K	0
Nov 7, 2025	Chevallard Daniel R.	Chief Financial Officer	Buy	2,198	$22.76	$50.0K	0
Nov 7, 2025	MCCOLLUM JAMES W	Director	Buy	10,500	$22.79	$239.3K	0
May 15, 2024	Chevallard Daniel R.	Chief Financial Officer	Buy	3,188	$15.68	$50.0K	3,188
May 14, 2024	MCCOLLUM JAMES W	Director	Buy	31,332	$15.99	$501.1K	525,565
Mar 25, 2024	RA CAPITAL MANAGEMENT, L.P.		Buy	998,009	$15.03	$15.00M3.2% OS	3,319,339+43%
Apr 13, 2022	Gutry Phil	CHIEF BUSINESS OFFICER	Buy	5,000	$4.01	$20.1K	299,941
Apr 13, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	424,464	$4.08	$1.73M1.4% OS	8,459,314
Jan 25, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	123,000	$8.94	$1.10M	8,034,850
Jan 21, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	97,670	$9.10	$888.7K	7,911,850
Dec 20, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	22,329	$10.19	$227.5K	7,814,180
Nov 24, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	201,685	$10.15	$2.05M0.6% OS	7,791,851
Oct 15, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	50,800	$13.14	$667.7K	7,590,166
Oct 8, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	145,496	$13.53	$1.97M	7,539,366
Jul 1, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	500,000	$17.00	$8.50M1.6% OS	7,393,870
Jul 1, 2021	Shah Smital	Director	Buy	5,882	$17.00	$100.0K	5,882
Jul 1, 2021	Versant Venture Capital VI, L.P.	10% Owner	Buy	180,000	$17.00	$3.06M0.6% OS	1,707,719

LENZ Insider Buying Activity

The following table shows recent insider purchases of LENZ Therapeutics, Inc. (LENZ) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 30, 2026	Schimmelpennink Evert B.	director, officer: President, CEO and Secretary	Buy	28,089	$8.95	$251.4K	77,289+57%
Mar 30, 2026	George Jeffrey P.	director	Buy	5,592	$8.92	$49.9K	5,592
Mar 30, 2026	Chevallard Daniel R.	officer: Chief Financial Officer	Buy	7,500	$8.57	$64.3K	12,886+139%
Nov 7, 2025	Chevallard Daniel R.	Chief Financial Officer	Buy	2,198	$22.76	$50.0K	0
Nov 7, 2025	MCCOLLUM JAMES W	Director	Buy	10,500	$22.79	$239.3K	0
May 15, 2024	Chevallard Daniel R.	Chief Financial Officer	Buy	3,188	$15.68	$50.0K	3,188
May 14, 2024	MCCOLLUM JAMES W	Director	Buy	31,332	$15.99	$501.1K	525,565
Mar 25, 2024	RA CAPITAL MANAGEMENT, L.P.		Buy	998,009	$15.03	$15.00M3.2% OS	3,319,339+43%
Apr 13, 2022	Gutry Phil	CHIEF BUSINESS OFFICER	Buy	5,000	$4.01	$20.1K	299,941
Apr 13, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	424,464	$4.08	$1.73M1.4% OS	8,459,314
Jan 25, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	123,000	$8.94	$1.10M	8,034,850
Jan 21, 2022	Samsara BioCapital, L.P.	10% Owner	Buy	97,670	$9.10	$888.7K	7,911,850
Dec 20, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	22,329	$10.19	$227.5K	7,814,180
Nov 24, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	201,685	$10.15	$2.05M0.6% OS	7,791,851
Oct 15, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	50,800	$13.14	$667.7K	7,590,166
Oct 8, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	145,496	$13.53	$1.97M	7,539,366
Jul 1, 2021	Samsara BioCapital, L.P.	10% Owner	Buy	500,000	$17.00	$8.50M1.6% OS	7,393,870
Jul 1, 2021	Shah Smital	Director	Buy	5,882	$17.00	$100.0K	5,882
Jul 1, 2021	Versant Venture Capital VI, L.P.	10% Owner	Buy	180,000	$17.00	$3.06M0.6% OS	1,707,719